Sinovac Biotech Ltd (SVA)

The 700+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September...

Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.

The government requires hedge funds and wealthy investors with over a certain portfolio size to file a report that shows their positions at the end of every quarter.

Anika Therapeutics, Inc. (NASDAQ:ANIK) was in 7 hedge funds' portfolio at the end of the first quarter of 2013.

With the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) up 28% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.